Previous studies have reported that ARs can bind with YAP1 and promote its nuclear translocation in prostate cancer cells to enhance cell survival (Cinar et al., 2020; Kuser-Abali et al., 2015). This evidence concerns the gene YAP1 and prostate carcinoma.